Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Orion drops development of gel formulation of progestin

Sep. 19, 2001

Long-term AICAR has beneficial metabolic and cardiovascular effects in rat IRS model

Sep. 18, 2001

Merck Frosst/AxyS collaboration identifies new cathepsin inhibitors

Sep. 17, 2001

AERx iDMS showcased at EASD meeting

Sep. 17, 2001

Potential new drug for removing cholesterol licensed to Samaritan

Sep. 17, 2001

Thirty-six-week follow-up data show maintenance of weight loss after treatment with Axokine

Sep. 17, 2001

Devgen and Metabolex work together in the area of diabetes

Sep. 17, 2001

Joint research at Karo Bio and Abbott leads to liver-selective GR antagonists

Sep. 14, 2001

Boehringer Ingelheim reports new piperazine MTP inhibitors

Sep. 14, 2001

Phase I rhASB trial successfully meets its primary objective

Sep. 14, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
Insilico Medicine synthesizes new Nav1.8 blockers
BioWorld Science
Insilico Medicine Inc. has identified sodium channel protein type 10 subunit α (SCN10A; Nav1.8) blockers that are potentially useful for the treatment of pain.